This is a preview of subscription content, log in via an institution to check access.
References
Avramoglou, T.; Jozefonvicz, J. Derivatized dextrans inhibition of smooth muscle cell proliferation in culture. J. Biomater. Sci. Polymer Edn. 3:149–154; 1991.
Bagheri-Yarmand, R.; Morere, J. F.; Letourneur, D., et al. Inhibitory effects of dextran derivatives in vitro on the growth characteristics of premalignant and malignant human mammary epithelial cell lines. Anticancer Res. 12:1641–1646; 1992.
Coffey, R. J.; Leof, E. B.; Shipley, G., et al. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell Physiol. 132:143–148; 1987.
Crepon, B.; Maillet, F.; Kazatchkine, M. D., et al. Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans. Biomaterials 8:248–253; 1987.
Fantini, J.; Guo, X. J.; Marvaldi, J., et al. Suramin inhibits proliferation of rat glioma cells and alters N-cam cell surface expression. Int. J. Cancer 45:554–561; 1990.
Kasayama, S.; Saito, H.; Kouhara, H., et al. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionagi carcinoma 115) cells. J. Cell. Physiol. 154:254–261; 1993.
Letourneur, D.; Logeart, D.; Avramoglou, T., et al. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers. Biomater. Sci. Polymer Edn. 4:431–444; 1993.
Letourneur, D.; Champion, J.; Slaoui, F., et al. In vitro stimulation of human endothelial cells by derivatized dextrans. In Vitro Cell. Dev. Biol. 29A:67–72; 1993.
Mauzac, M.; Jozefonvicz, J. Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization. Biomaterials 5:301–304; 1984.
Minniti, C. P.; Maggi, M.; Helman, L. J. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. Cancer Res. 52:1830–1835; 1992.
Morere, J. F.; Letourneur, D.; Planchon, P., et al. Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro. Anticancer Drugs 3:629–634; 1992.
Powis, G.; Seewald, M.; Hoke, M. Inhibition of growth factor binding and intracellular ca2+ signaling by dextran sulfates of different sizes and degrees of sulfation. Cancer Chemother. Pharmacol. 30:483–486; 1992.
Reilly, C. F.; Kindy, M. S.; Brown, K. E., et al. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J. Biol. Chem. 264:6990–6995; 1989.
Sanders, F. K.; Smith, J. D. Effect of collagen and acid polysaccharides on the growth of BHK/21 cells in semi-solid media. Nature 227:513–516; 1970.
Souttou, B.; Gamby, C.; Crépin, M., et al. Neoplastic transformation of the human breast epithelial cell line HBL100 with the FGF4 oncogene. Submitted; 1994.
Wellstein, A.; Zugmier, G.; Califono, J. A., et al. Tumor growth dependent on kaposi’s sarcoma derived fibroblast growth factor inhibited by pentosan polysulfate. JNCI 83:716–720; 1991.
Wright, T. C.; Johnstone, T. V.; Castellot, J. J., et al. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J. Cell Physiol. 125:499–506; 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bagheri-Yarmand, R., Bittoun, P., Champion, J. et al. Carboxymethyl benzylamide dextrans inhibit breast cell growth. In Vitro Cell Dev Biol - Animal 30, 822–824 (1994). https://doi.org/10.1007/BF02639391
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02639391